|
Video: What is a Stock Split?
|
|
Seelos Therapeutics is a biopharmaceutical company focused on the development of product candidates in the areas of urology and rheumatology. Co. has two product candidates : Vitaros, a topically-applied cream formulation of alprostadil for the treatment of erectile dysfunction, which Co. in-licensed from Warner Chilcott Company, Inc.; and RayVa, a topically-applied cream formulation of alprostadil designed to dilate blood vessels for the treatment of Raynaud's Phenomenon, secondary to scleroderma, for which it owns worldwide rights. According to our APRI split history records, APRI has had 1 split. | |
|
APRI (APRI) has 1 split in our APRI split history database. The split for APRI took place on October 24, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of APRI owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as APRI conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the APRI split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into APRI shares, starting with a $10,000 purchase of APRI, presented on a split-history-adjusted basis factoring in the complete APRI split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/17/2014 |
|
End date: |
01/23/2019 |
|
Start price/share: |
$17.70 |
|
End price/share: |
$0.22 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.76% |
|
Average Annual Total Return: |
-63.50% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$124.30 |
|
Years: |
4.35 |
|
|
|
Date |
Ratio |
10/24/2016 | 1 for 10 |
|
|